Cargando…
Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
Although significant progress has been made in the implementation of new breast cancer treatments over the last three decades, this neoplasm annually continues to show high worldwide rates of morbidity and mortality. In consequence, the search for novel therapies with greater effectiveness and speci...
Autores principales: | Huerta-Reyes, Maira, Maya-Núñez, Guadalupe, Pérez-Solis, Marco Allán, López-Muñoz, Eunice, Guillén, Nancy, Olivo-Marin, Jean-Christophe, Aguilar-Rojas, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779786/ https://www.ncbi.nlm.nih.gov/pubmed/31632902 http://dx.doi.org/10.3389/fonc.2019.00943 |
Ejemplares similares
-
Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231
por: Aguilar-Rojas, Arturo, et al.
Publicado: (2012) -
Gonadotropin-releasing hormone analogs: Understanding advantages and limitations
por: Kumar, Pratap, et al.
Publicado: (2014) -
The Effects of Gonadotropin-Releasing Hormone Analog and a Combination of Gonadotropin-Releasing Hormone Analog and Recombinant Human Growth Hormone on Adult Height in Girls with Early Puberty
por: Hajzadeh, Ghodsieh, et al.
Publicado: (2019) -
Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
por: Fleming, Richard
Publicado: (2022) -
Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)